Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
37.71
0.73 (1.99%)
At close: May 28, 2025, 3:59 PM
37.80
0.24%
After-hours: May 28, 2025, 04:40 PM EDT

Revolution Medicines Revenue Breakdown

Period Ending Dec 31, 2022 Dec 31, 2021
Collaboration Revenue Member Revenue 35.38M 29.39M
Collaboration Revenue Member Revenue Growth +20.38% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018
Selling, General, and Administrative Revenue 35.01M 28.21M 23.96M 21.71M 22.84M 31M 15.51M 14.64M 13.22M 10.91M 10.43M 10.2M 9.04M 8.69M 7.79M 7.3M 6.67M 5.83M 5.34M 5.09M 5.17M 4.16M 3.1M 2.73M 2.42M 3.83M
Selling, General, and Administrative Revenue Growth +24.09% +17.75% +10.36% -4.93% -26.33% +99.83% +5.96% +10.71% +21.21% +4.56% +2.25% +12.91% +3.97% +11.56% +6.77% +9.40% +14.51% +9.06% +4.91% -1.55% +24.24% +34.13% +13.87% +12.79% -37.00% n/a
Research and Development Revenue 205.75M 187.52M 151.75M 134.93M 118.02M 146.87M 107.73M 97.98M 68.95M 66.13M 69.45M 61M 56.49M 53.68M 46.47M 45.94M 40.86M 37.01M 34.87M 32.92M 27.46M 27.49M 22.96M 20.12M 21.19M 18.18M
Research and Development Revenue Growth +9.72% +23.57% +12.47% +14.33% -19.64% +36.32% +9.95% +42.11% +4.26% -4.79% +13.86% +7.99% +5.23% +15.51% +1.17% +12.43% +10.41% +6.12% +5.93% +19.89% -0.12% +19.72% +14.14% -5.05% +16.53% n/a